Elizabeth J Kailath, MD,MPH Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6614 Mercy Ct, Suite A, Fair Oaks, CA 95628 Phone: 916-536-1136 Fax: 916-536-1148 |
News Archive
One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system.
More than an estimated 160,000 people in the United States will die from lung cancer this year, making it the country's leading cause of cancer death. According to the National Cancer Institute, it surpassed breast cancer as the number one killer in women back in 1987. It causes more deaths than colon, breast and prostate cancer combined, according to the American Lung Association. Bruce Johnson, MD, the director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, sorts out the facts about lung cancer and offers simple ways to reduce risk.
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has agreed to acquire CardiAQ Valve Technologies, Inc., a privately held company and developer of a transcatheter mitral valve replacement system.
"Ignoring widespread concern over the safety, efficacy and cost of pentavalent vaccines" - which provide protection against diphtheria, pertussis, tetanus, hepatitis B and haemophilus influenza type b (Hib) - "India's central health ministry has, this month, approved inclusion of the prophylactic cocktail in the universal immunization program in seven of its provinces," Inter Press Service reports.
› Verified 8 days ago